First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.83 USD 8.54%
Updated: May 8, 2024

ADC Therapeutics SA
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ADC Therapeutics SA
PP&E Net Peer Comparison

Comparables:
ACIU
CRSP
BSLN
IDIA
KURN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
ADC Therapeutics SA
NYSE:ADCT
PP&E Net
$16.1m
CAGR 3-Years
50%
CAGR 5-Years
61%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
PP&E Net
CHf6.9m
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
PP&E Net
$305.9m
CAGR 3-Years
49%
CAGR 5-Years
75%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
PP&E Net
CHf20.6m
CAGR 3-Years
57%
CAGR 5-Years
26%
CAGR 10-Years
5%
Idorsia Ltd
SIX:IDIA
PP&E Net
CHf245.5m
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
PP&E Net
CHf2.6m
CAGR 3-Years
1%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is ADC Therapeutics SA's PP&E Net?
PP&E Net
16.1m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's PP&E Net amounts to 16.1m USD.

What is ADC Therapeutics SA's PP&E Net growth rate?
PP&E Net CAGR 5Y
61%

Over the last year, the PP&E Net growth was 61%. The average annual PP&E Net growth rates for ADC Therapeutics SA have been 50% over the past three years , 61% over the past five years .